|
Bravo-Gutierrez FJ, Miralles-Lopez JC, Valverde-Molina J, Alemany Frances ML, Andujar-Espinosa R, Castilla-Martinez M, Aviles-Ingles MJ, Mora-Gonzalez A, Pajaron-Fernandez MJ, Cabrejos-Perotti S, Meseguer-Arce J, Flores Martin I, Perez-Fernandez V; RE-ASGRAMUR Group. Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study. Int Arch Allergy Immunol. 2024;185(3):253-259. doi: 10.1159/000534902. Epub 2023 Nov 30. PubMed PMID: 38035559.
AÑO: 2024; IF: 2.5
|
38035559
|
Miralles-Lopez JC, Andujar-Espinosa R, Bravo-Gutierrez FJ, Cabrejos-Perotti S, Ramirez-Hernandez M, Diaz-Chantar C, Pajaron-Fernandez MJ, Valverde-Molina J, Perez-Fernandez V; RE-ASGRAMUR GROUP. Tezepelumab in Patients With Severe Asthma: Response at 3 Months. J Investig Allergol Clin Immunol. 2024 Nov 25:0. doi: 10.18176/jiaci.1041. Online ahead of print. No abstract available. PubMed PMID: 39584417.
AÑO: 2024; IF: 6.1
|
|
Castilla-Martinez M, Andujar-Espinosa R, Flores-Martin I, Reyes Cotes MH, Cabrejos-Perotti S, Miralles-Lopez JC, Carbonell-Martinez A, Bravo-Gutierrez FJ, Valverde-Molina J, Perez-Fernandez V; RE-ASGRAMUR GROUP. Early Effectiveness of Dupilumab in Patients With Type 2 Severe Asthma: A Prospective Real-Life Study. J Investig Allergol Clin Immunol. 2023 Apr 18;33(2):126-128. doi: 10.18176/jiaci.0872. Epub 2022 Nov 24. No abstract available. PubMed PMID: 36420744.
AÑO: 2023; IF: 6.1
|
|
Padilla-Galo A, Moya Carmona I, Ausin P, Carazo Fernandez L, Garcia-Moguel I, Velasco-Garrido JL, Andujar-Espinosa R, Casas-Maldonado F, Martinez-Moragon E, Martinez Rivera C, Vera Solsona E, Sanchez-Toril Lopez F, Trisan Alonso A, Blanco Aparicio M, Valverde-Monge M, Valencia Azcona B, Palop Cervera M, Nuevo J, Sanchez Tena J, Resler G, Luzon E, Levy Naon A. Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study. Respir Res. 2023 Sep 28;24(1):235. doi: 10.1186/s12931-023-02539-7. PubMed PMID: 37770889; PubMed Central PMCID: PMC10540395.
AÑO: 2023; IF: 4.7
|
|
Entrenas-Castillo M, Salinero-Gonzalez L, Entrenas-Costa LM, Andujar-Espinosa R. Calcifediol for Use in Treatment of Respiratory Disease. Nutrients. 2022 Jun 13;14(12):2447. doi: 10.3390/nu14122447. PubMed PMID: 35745177; PubMed Central PMCID: PMC9231174.
AÑO: 2022; IF: 6.706
|